🇺🇸 FDA
Patent

US 8697060

Treatment method for relapsing-remitting multiple sclerosis

granted A61KA61K2239/31A61K2239/38

Quick answer

US patent 8697060 (Treatment method for relapsing-remitting multiple sclerosis) held by REGENEX LLC expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENEX LLC
Grant date
Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2239/31, A61K2239/38, A61K40/11, A61K40/22